Rhinovirus-Infected Patients in the COVID-19 Pandemic Period

Watanabe, Yuji; Kamioka, Yasuhiro; Seki, Masafumi

doi:10.2147/idr.s300001

Cited by 8 publications

(8 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study evidenced that while there was a decline in the positivity rates of other respiratory viruses, the diffusion of rhinovirus seems not to be affected, and it was frequently detected during the pandemic. We observed an increase in its circulation; a finding confirmed by other studies [ 36 , 37 , 38 ]. The different pattern might be due to their greater stability under environmental conditions (e.g., heat, desiccation, and pH values) than enveloped viruses.…”

Section: Discussionsupporting

confidence: 92%

Circulation of Respiratory Viruses in Hospitalized Adults before and during the COVID-19 Pandemic in Brescia, Italy: A Retrospective Study

Francesco

Pollara

Gargiulo

et al. 2021

IJERPH

View full text Add to dashboard Cite

Different preventive public health measures were adopted globally to limit the spread of SARS-CoV-2, such as hand hygiene and the use of masks, travel restrictions, social distance actions such as the closure of schools and workplaces, case and contact tracing, quarantine and lockdown. These measures, in particular physical distancing and the use of masks, might have contributed to containing the spread of other respiratory viruses that occurs principally by contact and droplet routes. The aim of this study was to evaluate the prevalence of different respiratory viruses (influenza viruses A and B, respiratory syncytial virus, parainfluenza viruses 1, 2, 3 and 4, rhinovirus, adenovirus, metapneumovirus and human coronaviruses) after one year of the pandemic. Furthermore, another aim was to evaluate the possible impact of these non-pharmaceutical measures on the circulation of seasonal respiratory viruses. This single center study was conducted between January 2017–February 2020 (pre-pandemic period) and March 2020–May 2021 (pandemic period). All adults >18 years with respiratory symptoms and tested for respiratory pathogens were included in the study. Nucleic acid detection of all respiratory viruses was performed by multiplex real time PCR. Our results show that the test positivity for influenza A and B, metapneumovirus, parainfluenza virus, respiratory syncytial virus and human coronaviruses decreased with statistical significance during the pandemic. Contrary to this, for adenovirus the decrease was not statistically significant. Conversely, a statistically significant increase was detected for rhinovirus. Coinfections between different respiratory viruses were observed during the pre-pandemic period, while the only coinfection detected during pandemic was between SARS-CoV-2 and rhinovirus. To understand how the preventive strategies against SARS-CoV-2 might alter the transmission dynamics and epidemic patterns of respiratory viruses is fundamental to guide future preventive recommendations.

show abstract

Section: Discussionsupporting

confidence: 92%

Circulation of Respiratory Viruses in Hospitalized Adults before and during the COVID-19 Pandemic in Brescia, Italy: A Retrospective Study

Francesco

Pollara

Gargiulo

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…These respiratory infections are those mostly seen in moderate to severe COVID-19 infection. One of the most important respiratory pathogens in COVID-19 is the human rhinovirus known to cause rhino-bronchitis 23 meanwhile cough is one of the most common presenting symptoms of COVID-19, along with fever and loss of taste and smell 24 . When persist for weeks or months after SARS-CoV-2 infection, cough is accompanied by chronic fatigue, cognitive impairment, dyspnea, or pain 24 .…”

Section: Characterization Of Plants Directed Against Respiratory Tract Diseasesmentioning

confidence: 99%

Systematic Review of Plants Used Against Respiratory Diseases Related to COVID-19 in Africa

Agbor

Ndjib

2021

J. Drug Delivery Ther.

View full text Add to dashboard Cite

Background: Respiratory disorders are known to affect the airways including the nasal passages, bronchi and lungs causing blockages. The advent of COVID-19 has further aggravated the complications of the respiratory systems where conventional medicine is not reachable or affordable by the majority poor in Africa. Hence, the over 80% of the African population who turn to traditional medicine for their primary health care. Objective: This review is aimed to identify plants directed against respiratory diseases which can be useful in the fight against COVID-19. Methodology: Scientific articles selected in this study span the last ten years (2011-2021). Keywords such as “ethnobotany in Africa”, “ethnobotany and respiratory diseases” “medicinal plants and respiratory diseases”, “traditional medicine and COVID-19” were searched in open access search engines such as: Science Direct, Research Gate, Google Scholar, Pubmed, Web of Science, Scopus. The ethnobotanical indices were then calculated using Microsoft excel to determine the plants with the most therapeutic potential to be considered for the local management of COVID-19. Results: Data obtained were classified according to country of origin of the author of the publication, the botanical family and the respiratory pathology being treated. Thirteen (13) references were finally selected with the represented country being Benin Republic. One hundred and forty-three plant species belonging to 60 families were registered. The most recurrent families were the Fabaceae and Lamiaceae (18 citations each). The plants in these families were used for the management of fifteen diseases and / or symptoms relating to the respiratory system. The most cited plants were: Ocimum gratissimum L. (4 citations), Entandrophragma cylindrium (Sprague), Scyphocephalium ochocoa Warb., Rubia cordifolia and Allium sativum L. (3 citations each). Conclusion: Based on the data obtained in this review Ocimum gratissimum stands out as the most used plant for the treatment of respiratory disorders. Keywords: Respiratory diseases, Medicinal plants, COVID-19

show abstract

“…Even though there was an increase in the detection rate of RSV with the easing of public health measures, the influenza positivity remained at very low levels 15 . However, an increase in the circulation of rhinovirus was observed in Canada, as in Japan and Turkey 39,40 , which is often attributed to the greater environmental stability of non-enveloped viruses and greater efficacy of face masks in filtering out enveloped viruses. 41 There was a significant disparity in the number of weeks during which the samples were procured for surveillance.…”

Section: Discussionmentioning

confidence: 99%

The impact of COVID-19 pandemic on influenza surveillance: a systematic review and meta-analysis

Sabeena¹,

Ravishankar

Robin

2022

Preprint

View full text Add to dashboard Cite

Influenza activity was reported to be below the seasonal levels during the COVID-19 pandemic globally. However, during the SARS-CoV-2 outbreak, the routine real-time surveillance of influenza like illness (ILI) and acute respiratory infection (ARI) was adversely affected due to the changes in priorities, economic constraints, repurposing of hospitals for COVID care and closure of outpatient services. A systematic review and meta-analysis were carried out to assess the pooled proportion of symptomatic cases tested for influenza virus before the COVID-19 pandemic in 2019 and during the pandemic in 2020/2021. The study was designed based on PRISMA guidelines and the meta-analysis was performed to synthesise the pooled proportion of patients sampled for influenza surveillance before the COVID-19 pandemic in 2019 and during the pandemic in 2020/21 with 95% confidence interval (CI). The overall pooled proportion of symptomatic cases undergone influenza surveillance before and during the pandemic was 2.38% (95% CI 2.08%-2.67%) and 4.18% (95% CI 3.8%-4.52%) respectively. However, the pooled proportion of samples tested for influenza before the pandemic was 0.69% (95% CI 0.45-0.92%) and during the pandemic was 0.48% (95% CI 0.28-0.68%) when studies from Canada were excluded. The meta-analysis concludes that globally there was a decline in influenza surveillance during the COVID-19 pandemic except in Canada.

show abstract

Rhinovirus-Infected Patients in the COVID-19 Pandemic Period

Cited by 8 publications

References 6 publications

Circulation of Respiratory Viruses in Hospitalized Adults before and during the COVID-19 Pandemic in Brescia, Italy: A Retrospective Study

Circulation of Respiratory Viruses in Hospitalized Adults before and during the COVID-19 Pandemic in Brescia, Italy: A Retrospective Study

Systematic Review of Plants Used Against Respiratory Diseases Related to COVID-19 in Africa

The impact of COVID-19 pandemic on influenza surveillance: a systematic review and meta-analysis

Contact Info

Product

Resources

About